Use of Patents for International Humanitarian Purposes to Address Public Health Problems (Canada's Access to Medicines Regime)
- Background
- Brief Description
- Obtaining an Authorization in Canada
- Communications with CIPO
- Process and Forms
- Responsibilities of the Canadian Pharmaceutical Manufacturer
- Health Canada Requirements
- CIPO Requirements
- Form 1: Application for authorization under section 21.04 of the Patent Act DOC 57KB
- Form 2: Solemn or statutory declaration under paragraph 21.04(3)(c) of the Patent Act DOC 45KB
- Form 3: Solemn or statutory declaration under clause 21.04(3)(d)(i)(A) of the Patent Act DOC 43KB
- Form 4: Solemn or statutory declaration under clause 21.04(3)(d)(i)(B) of the Patent Act DOC 41KB
- Form 5: Solemn or statutory declaration under clause 21.04(3)(d)(ii)(A) of the Patent Act DOC 44KB
- Form 6: Solemn or statutory declaration under clause 21.04(3)(d)(ii)(B) of the Patent Act DOC 42KB
- Form 7: Solemn or statutory declaration under clause 21.04(3)(d)(iii)(A),(iv)(A) or (v)(A) of the Patent Act DOC 42KB
- Form 8: Solemn or statutory declaration under paragraph 21.16(1)(b) of the Patent Act DOC 45KB
- Maintain a Web site
- Pay Royalties
- Notice of Export
- Form 10: Application for renewal of authorization under section 21.12 of the Patent Act DOC 57KB
- CIPO Responsibilities
- Applications for Authorizations Received by CIPO
- Web sites of Holders of Authorizations
- Other Links
